SNDX vs. AEHR
SNDX (Syndax Pharmaceuticals, Inc.) and AEHR (Aehr Test Systems) are both stocks. SNDX operates in Biotechnology (Healthcare), while AEHR operates in Semiconductor Equipment & Materials (Technology). Over the past 10 years, SNDX returned 6.29%/yr vs 50.48%/yr for AEHR. At a 0.17 correlation, their price movements are largely independent.
Performance
SNDX vs. AEHR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SNDX achieves a -6.66% return, which is significantly lower than AEHR's 407.13% return. Over the past 10 years, SNDX has underperformed AEHR with an annualized return of 6.29%, while AEHR has yielded a comparatively higher 50.48% annualized return.
SNDX
- 1D
- 1.50%
- 1M
- -1.65%
- YTD
- -6.66%
- 6M
- -9.63%
- 1Y
- 113.38%
- 3Y*
- -2.13%
- 5Y*
- 1.56%
- 10Y*
- 6.29%
AEHR
- 1D
- -9.65%
- 1M
- 7.76%
- YTD
- 407.13%
- 6M
- 349.67%
- 1Y
- 810.13%
- 3Y*
- 36.85%
- 5Y*
- 107.37%
- 10Y*
- 50.48%
SNDX vs. AEHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SNDX Syndax Pharmaceuticals, Inc. | -6.66% | 58.93% | -38.82% | -15.09% | 16.26% | -1.57% | 153.30% | 97.30% | -49.20% | 22.18% |
AEHR Aehr Test Systems | 407.13% | 21.41% | -37.32% | 31.99% | -16.87% | 855.73% | 26.50% | 41.84% | -47.97% | 12.45% |
Correlation
The correlation between SNDX and AEHR is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Mar 3, 2016 | 0.17 |
Fundamentals
SNDX:
-$3.75
AEHR:
-$0.38
SNDX:
5.86
AEHR:
68.38
SNDX:
$217.17M
AEHR:
$45.26M
SNDX:
$208.46M
AEHR:
$13.90M
SNDX:
-$171.20M
AEHR:
-$13.56M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SNDX vs. AEHR — Risk / Return Rank
SNDX
AEHR
SNDX vs. AEHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Syndax Pharmaceuticals, Inc. (SNDX) and Aehr Test Systems (AEHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SNDX | AEHR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -4.83 | ||
| Sortino ratioReturn per unit of downside risk | -1.49 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 1.51 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | 3.50 | 19.34 | -15.83 |
| Martin ratioReturn relative to average drawdown | 10.20 | 43.44 | -33.25 |
Loading charts...
Drawdowns
SNDX vs. AEHR - Drawdown Comparison
The maximum SNDX drawdown since its inception was -78.98%, smaller than the maximum AEHR drawdown of -97.98%. Use the drawdown chart below to compare losses from any high point for SNDX and AEHR.
Loading charts...
Drawdown Indicators
| SNDX | AEHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.98% | -97.98% | +19.00% |
Max Drawdown (1Y)Largest decline over 1 year | -32.56% | -42.31% | +9.75% |
Max Drawdown (3Y)Largest decline over 3 years | -64.81% | -87.37% | +22.56% |
Max Drawdown (5Y)Largest decline over 5 years | -69.88% | -87.37% | +17.49% |
Max Drawdown (10Y)Largest decline over 10 years | -78.98% | -87.37% | +8.39% |
Current DrawdownCurrent decline from peak | -32.33% | -12.17% | -20.16% |
Average DrawdownAverage peak-to-trough decline | -35.80% | -79.53% | +43.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.16% | 18.80% | -7.64% |
Volatility
SNDX vs. AEHR - Volatility Comparison
The current volatility for Syndax Pharmaceuticals, Inc. (SNDX) is 9.53%, while Aehr Test Systems (AEHR) has a volatility of 38.64%. This indicates that SNDX experiences smaller price fluctuations and is considered to be less risky than AEHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SNDX | AEHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.53% | 38.64% | -29.11% |
Volatility (6M)Calculated over the trailing 6-month period | 32.21% | 88.90% | -56.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.88% | 119.59% | -62.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 54.69% | 110.16% | -55.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 71.10% | 94.02% | -22.92% |
Dividends
SNDX vs. AEHR - Dividend Comparison
Neither SNDX nor AEHR has paid dividends to shareholders.
Financials
SNDX vs. AEHR - Financials Comparison
This section allows you to compare key financial metrics between Syndax Pharmaceuticals, Inc. and Aehr Test Systems. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SNDX vs. AEHR - Profitability Comparison
SNDX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Syndax Pharmaceuticals, Inc. reported a gross profit of 62.23M and revenue of 64.86M. Therefore, the gross margin over that period was 95.9%.
AEHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aehr Test Systems reported a gross profit of 3.37M and revenue of 10.31M. Therefore, the gross margin over that period was 32.7%.
SNDX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Syndax Pharmaceuticals, Inc. reported an operating income of -34.20M and revenue of 64.86M, resulting in an operating margin of -52.7%.
AEHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aehr Test Systems reported an operating income of -4.23M and revenue of 10.31M, resulting in an operating margin of -41.0%.
SNDX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Syndax Pharmaceuticals, Inc. reported a net income of -42.67M and revenue of 64.86M, resulting in a net margin of -65.8%.
AEHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aehr Test Systems reported a net income of -3.20M and revenue of 10.31M, resulting in a net margin of -31.1%.
Frequently Asked Questions
SNDX and AEHR have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AEHR has higher volatility (38.64%) compared to SNDX (9.53%). In terms of maximum drawdown, SNDX dropped -78.98% vs AEHR's -97.98%.
AEHR currently has the higher Sharpe Ratio (6.84 vs 2.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SNDX and AEHR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer